Consistent with those findings, mRNA expressions of NFATc1 (Nfatc1), a master regulator of osteoclastogenesis, and the osteoclastic marker protein cathepsin K (Ctsk) and osteoclast-associated receptor (Oscar) were significantly decreased in PD-drug treated cells (Fig. 2D). This evidence concerns the gene CTSK and Parkinson disease.